Therefore, although both trials highlight the prognostic value of NT-proBNP and hs-cTnT in asymptomatic severe AS, current evidence suggests that these biomarkers alone are insufficient to guide clinical decision-making regarding the timing of TAVR. Here, TNNT2 is linked to aortic stenosis.